Healthcare Private Equity

Goodwin’s Healthcare Private Equity practice provides a complete, end-to-end service offering that combines the firm’s market-leading transactional capabilities with a deep knowledge of healthcare regulations and the healthcare market.

Goodwin offers a national platform and leverages its deep corporate experience and holistic knowledge of healthcare regulations and the healthcare markets to help private equity firms and portfolio companies complete transactions and realize their strategic objectives. Our Healthcare Private Equity practice combines private equity deal-making experience with one of the nation’s leading healthcare regulatory compliance practices to deliver practical advice on buy- and sell-side transactions across the healthcare marketplace.

Healthcare transactions are driven by regulations. Private equity firms may face significant risk if their deals are not properly structured, so they often engage separate special regulatory and transactional counsel to handle their transactions. We combine our healthcare regulatory experience — including, among others, fraud and abuse, Anti-Kickback Statute, Stark, False Claims Act, HIPAA, licensing, certificates of need, corporate practice of medicine, and reimbursement — with our corporate, M&A, and transactional capabilities, and deep knowledge of the healthcare markets to obtain optimal outcomes for clients in a one-stop shop environment.

Our clients include many of the largest private equity firms, including multiple firms with a specific focus on healthcare investments. We represent fund and portfolio company clients in all of the issues encountered in the life cycle of an private equity fund. Our team focuses on five main areas: buyouts, growth equity, private investment funds, debt finance, and portfolio companies.

We work hand in glove with our private equity clients to achieve efficient and swift transaction closings, and thereafter work with their portfolio companies to ensure state-of-the-art compliance, streamlined roll-up programs and an exit-ready profile for a smooth sale process.

Additionally, transactions often involve general business issues outside of healthcare. We offer a deep bench in all areas critical to deal success and regularly assemble knowledgeable transaction teams tailored to the specific issues involved in a deal including litigation, intellectual property, data, privacy and cybersecurity, executive compensation, labor and employment, and tax.

Healthcare providers and suppliers face continuing regulatory compliance issues, long after a transaction closes. We represent sponsors and portfolio companies in dealing with regulatory issues affecting daily operations, as well as subsequent commercial transactions. Goodwin’s experienced attorneys work to keep clients up-to-date on the latest legal and regulatory changes that affect their businesses, and to assist with compliance efforts.

We also provide sophisticated counsel for private + publicly-traded companies, as well as tender offers, proxy contests, corporate restructurings, divestitures, joint ventures, spinoffs, change in control and other transactional (M&A) events.